Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Expression of NKG2D activating ligand proteins for sensitizing cancer cells to attack by cytotoxic immune cells

Expression of NKG2D activating ligand proteins for sensitizing cancer cells to attack by cytotoxic immune cells

US Patent 11427625 · Granted Aug 30, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antigenically stealthed oncolytic viruses2025
Oncolytic HSV vector2024
Oncolytic HSV vector2024
Targeted delivery of glycine receptors to excitable cells2023
Identification of mutations in herpes simplex virus envelope glycoproteins that 2022
TRPV1 modulatory gene product that affects TRPV1-specific pain behavioral respon2020
Retinoid compositions and methods of increasing immune cell-mediated killing of 2020
Targeted delivery of glycine receptors to excitable cells2020
Oncolytic HSV vector2020
Oncolytic HSV vector2020
Identification of mutations in herpes simplex virus envelope glycoproteins that 2019
Oncolytic HSV vector2019